Print
PDF
For Release:
Contact:
Immediately
Dr Nick Hutchinson
Market Development Manager (Pharma & Biotech), Process Filtration
Tel: +44 (0)191 301 4072
Email: This e-mail address is being protected from spambots. You need JavaScript enabled to view it

Parker acquires SciLog Inc to strengthen single-use system capability

Parker Hannifin Corporation has announced the acquisition of SciLog Inc, a provider of unique and proprietary single-use technologies and systems for the biopharmaceutical market to support their on-going development as a key supplier to the growing single-use market. The acquisition will allow Parker to deliver an enhanced bioprocessing portfolio combining filtration and separation expertise, disposable bag systems and automated single-use solutions.

SciLog will be integrated into Parker's Process Filtration Division, which provides high-purity filtration and separation solutions coupled with disposable bags and tubing assemblies for applications such as cell culture media and buffer preparation, product stream filtration and sterile fill finish. Parker's offering to customers will be enhanced through the addition of SciLog's patented sensor technology for process monitoring and control coupled with unique automation technology from lab to production scale in upstream and downstream processing.

"The addition of SciLog perfectly complements our existing core strengths in filtration and disposable assemblies for the biopharmaceutical market," said Dr Mike Brailsford, General Manager at Parker's Process Filtration Division. "Our customers will now benefit from complete, turnkey solutions that enhance productivity, increase cost-effectiveness and facilitate processing units of operation such as buffer / media prep, virus inactivation etc."

"Today SciLog becomes a global business," said Juliette Schick, CEO and President of SciLog, "With this acquisition SciLog now has a platform in Parker to access global markets, distribution channels and resources to maximize SciLog's single-use product offerings and patent positions."

Parker's expanded capabilities in the biopharmaceutical market will be delivered globally through an extensive and growing global technical support network coupled with customer support centres in over 50 countries.

---Ends---

About SciLog Inc.
SciLog Inc, based in Madison, Wisconsin, was established in 1990. It provides sensor technology and automated lab-scale and production systems for the biopharmaceutical industry.

About Parker Hannifin Corporation
With annual sales exceeding $13 billion in fiscal year 2012, Parker Hannifin is the world's leading diversified manufacturer of motion and control technologies and systems, providing precision-engineered solutions for a wide variety of mobile, industrial and aerospace markets. The company employs approximately 60,000 people in 48 countries around the world. Parker has increased its annual dividends paid to shareholders for 56 consecutive fiscal years, among the top five longest-running dividend-increase records in the S&P 500 index. For more information, visit the company's web site at www.parker.com, or its investor information web site at www.phstock.com.

###

For more information contact:

Parker Hannifin Ltd
domnick hunter
Process Filtration – Europe
Durham Road
Birtley, Co Durham
DH3 2SF
phone: +44 (0)191 410 5121
fax: +44 (0)191 410 5312
email: This e-mail address is being protected from spambots. You need JavaScript enabled to view it
www.parker.com/processfiltration
Parker Hannifin Corporation
domnick hunter
Process Filtration – North America
2340 Eastman Avenue
Oxnard, California, USA, 93030
toll free: +1 877 784 2234
phone: +1 805 604 3400
fax: +1 805 604 3401
email: This e-mail address is being protected from spambots. You need JavaScript enabled to view it
www.parker.com/processfiltration
Issued by:
Pinnacle Marketing Communications Ltd,
Green Park House, 15 Stratton Street, London, W1J 8LQ
Tel: +44 (0) 20 8869 9339    Fax: +44 (0) 20 8868 4373
Web: www.pinnacle-marketing.com
E-mail: This e-mail address is being protected from spambots. You need JavaScript enabled to view it
August 2012
Ref: PAR176